The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Umstead John W. V since 2024.
This trader's CIK number is 1967910.
At the time of last reporting, Umstead John W. V was the Chief Financial Officer of G1 Therapeutics, Inc.. (stock ticker symbol GTHX).
Also see all insider trading activities at G1 Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | GTHX | 0 | $0 | 15,968 | $62,405 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-07-05 | GTHX | Sale | 527 | 2.51 | 1,321 |
| 2024-05-13 | GTHX | Sale | 8,151 | 4.79 | 39,035 |
| 2024-03-18 | GTHX | Sale | 6,547 | 3.02 | 19,752 |
| 2024-01-04 | GTHX | Sale | 111 | 2.94 | 326 |
| 2024-01-03 | GTHX | Sale | 632 | 3.12 | 1,971 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Umstead John W. V (Chief Financial Officer of G1 Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.